(Q36028669)

11 August 2017

1 reference

title

Histone deacetylase inhibitors and cancer therapy (English)

1 reference

11 August 2017

N B La Thangue

1

1 reference

PubMed ID

15688613

11 August 2017

language of work or name

1 reference

1 November 2004

1 reference

11 August 2017

Journal of Chemotherapy

1 reference

11 August 2017

16 Suppl 4

1 reference

11 August 2017

64-67

1 reference

Translating the Histone Code

11 August 2017

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.64

Histone deacetylases (HDACs): characterization of the classical HDAC family

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.64

Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.64

Valproate and valproate-analogues: potent tools to fight against cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.64

Chronic oral administration of CI-994: a phase 1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.64

The cell cycle, chromatin and cancer: mechanism-based therapeutics come of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.64

Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.64

Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.64

The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.64

The interaction of histone deacetylase inhibitors and DNA methyltransferase inhibitors in the treatment of human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.64

Identification of novel isoform-selective inhibitors within class I histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2004.16.SUPPLEMENT-1.64

10.1179/JOC.2004.16.SUPPLEMENT-1.64

21 January 2018

Identifiers

DOI

0 references

PubMed ID

15688613

1 reference

PubMed ID

15688613